Additionally, SERPINC1, known as antithrombin III, is an FDA-approved anticoagulant and was included here due to its therapeutic potential against COVID-19 (ClinicalTrials.gov registration no. NCT04745442). This evidence concerns the gene SERPINC1 and COVID-19.